Meta-Analysis of Aspirin Versus Dual Antiplatelet Therapy Following Coronary Artery Bypass Grafting
Nayan Agarwal(Brigham and Women's Hospital), Deepak L. Bhatt(Mount Sinai Hospital), Arman Qamar(NorthShore University HealthSystem), Nirmanmoh Bhatia(Vanderbilt University Medical Center), Ankur Jain(University of Florida), Nimesh Patel(East Kent Hospitals University NHS Foundation Trust), Mohammad K. Mojadidi(Virginia Commonwealth University), Tanush Gupta(University of Vermont Medical Center), Jalaj Garg(Westchester Medical Center), Harsh Golwala(Brigham and Women's Hospital), Ahmed N. Mahmoud(University of Florida), Sahil Agrawal(St. Luke's University Health Network), R. David Anderson(Cancer Trials Ireland)
Cited by 47
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
|New England Journal of Medicine|2015|2k